![]()
|
Dimitris K. Agrafiotis is Vice
President of Informatics at Johnson & Johnson Pharmaceutical Research &
Development. He also serves as Adjunct Professor of Informatics at Indiana University
School of Informatics and the University of Athens School of
Pharmacy. After
finishing his undergraduate studies in chemistry in Greece, he moved to Imperial College, University of
London, where he received his Ph.D. in theoretical organic chemistry
under the directions of Prof. H. Rzepa. Following
post-doctoral training with Prof. A.
Streitwieser at the University of California, Berkeley, and Nobel laureate
Prof. E. J. Corey
at Harvard, he
joined Parke-Davis Pharmaceutical Research (now Pfizer) as a Senior
Scientist in the Computer-Aided Drug Design group. In 1994, he moved to
3-Dimensional Pharmaceuticals (3DP) where he focused on the development of
intelligent computational tools for combinatorial chemistry and
structure-based drug design, serving as Executive Director of Informatics.
Following the acquisition of 3DP by Johnson & Johnson PRD in 2003, he was
appointed Senior Research Fellow and Team Leader of the Molecular Design and
Informatics group at the US Research & Early Development site, and
directed the development of ABCD, a new global informatics platform for J&J PRD
(see also Nature Rev. Drug Discov. 2007, BioIT World 2006, and BioIT World 2007). In his
current role, he oversees all information management systems for research
& early development worldwide, and is responsible for setting global
information technology strategy and architecture for J&J pharmaceutical
R&D. He also directed the ERIS program, a global
regulatory information management system aimed at harmonizing electronic
submissions to the health authorities around the world, and is actively
involved in the development of a new generation of informatics solutions to
support clinical, epidemiological, and translational research. His
research spans many areas of computational chemistry and biology, including
computer-assisted drug design, chemo- and bioinformatics, data mining,
visualization, artificial intelligence and software engineering. He is the
author of 80 scientific publications and book chapters, and co-inventor of 18
patents. He serves on the Editorial Boards of the Journal of Chemical
Information and Modeling, Molecular
Informatics, Chemical
Biology & Drug Design, Journal of Molecular Graphics and Modeling, and Molecular
Diversity, the Boards of the International QSAR &
Modeling Society and the Chemical
Structure Association Trust, and the Scientific Advisory Boards of the NIH Exploratory Centers for Chemoinformatics
Research at Indiana University,
University of North Carolina, and Rensselaer Polytechnic Institute, as
well as the Environmental
Bioinformatics and Computational Toxicology Center at Rutgers University.
He frequently
delivers invited lectures, serves as symposium organizer at national and
international conferences, and participates in grant review boards. |
|